Frankfurt - Delayed Quote EUR

Stryker Corporation (SYK.F)

Compare
371.40
+1.90
+(0.51%)
At close: January 17 at 5:46:00 PM GMT+1

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Kevin A. Lobo Chairman, CEO & President 5.54M 32.73M 1965
Mr. Glenn S. Boehnlein CPA VP & CFO 2.2M 5.28M 1962
Mr. Viju S. Menon Group President of Global Quality & Operations 1.63M -- 1968
Mr. J. Andrew Pierce Group President of MedSurg & Neurotechnology 1.97M 2.61M 1974
Mr. Spencer S. Stiles Group President of Orthopaedics & Spine 1.97M 2.27M 1977
Mr. William E. Berry Jr. VP & Chief Accounting Officer -- -- 1966
Mr. Robert C. Cohen CTO and VP of Global R&D - Joint Replacement -- -- --
Mr. Alan Douville VP, Chief Information Officer & Chief Information Security Officer -- -- --
Mr. Jason Beach Vice President of Finance & Investor Relations -- -- --
Mr. Robert S. Fletcher VP & Chief Legal Officer 869.7k -- 1971

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600 https://www.stryker.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
52,000

Description

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Corporate Governance

Stryker Corporation’s ISS Governance QualityScore as of January 1, 2025 is 6. The pillar scores are Audit: 9; Board: 4; Shareholder Rights: 6; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 28, 2025 at 9:05 PM UTC

Stryker Corporation Earnings Date

Recent Events

January 2, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers